John Thornback

Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.

Apta Biosciences Ltd. develops and commercializes synthetic antibody alternatives. It is a synthetic biology company specialized in developing unique, proprietary molecules that can be used broadly across diagnostics and therapeutics to facilitate and expand scientific discovery enabling the development of new healthcare solutions. The company was founded by Fredrik Edenius, William Addison and Shozo Fujita in 2013 and is headquartered in London, the United Kingdom.

Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003.

Specialist Diabetes Research & Treatment Centre LLC specializes in diabetes treatment, research, training and public health awareness. Its services include diabetes, endocrinology, bariatric & metabolic, antenatal, cardiology, nephrology, podiatry, ophthalmology, radiology, dietetic services, laboratory, and pharmacy. The company was founded in May 2006 and is headquartered Abu Dhabi, United Arab Emirates.

Part of Thermo Fisher Scientific, Inc., Medgenix Diagnostics SA is a Belgian company that specializes in making radioimmunology assays for in-vitro use. Medgenix Diagnostics was acquired by Biosource International, Inc. from MDS Nordion, Inc. on June 05, 1996 for $6.87 million.

Aerelink Ltd. provides wireless networking services. The private company is based in Widnes, UK. and has subsidiaries in United Kingdom.